Nuzenio

Advance Phase

Advance Phase news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Vedanta Biosciences Raises $60 Million To Advance Phase 3 VE303 Study - Pulse 2.0Pulse 2.0 · Thu, 06 Aug 2026 14:18:46 GMTPepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review - BioSpaceBioSpace · Thu, 06 Aug 2026 12:39:14 GMTVedanta Biosciences Raises $60 Million to Advance Phase 3 VE303 Program - citybiz.cocitybiz.co · Thu, 06 Aug 2026 12:30:53 GMTPentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program - TradingViewTradingView · Thu, 06 Aug 2026 06:00:00 GMTSanofi-backed Expedition uses $115M series B to advance COPD drug on phase 2 journey - Fierce BiotechFierce Biotech · Wed, 05 Aug 2026 12:02:58 GMTNeurotech International (ASX:NTI) Raises $4.5 Million to Advance NTI164 Phase III Autism Clinical Trial - KalkineKalkine · Tue, 04 Aug 2026 01:12:00 GMTCeruvia Raises $8 Million to Advance Phase 1/2 Trial of Cluster Headache Therapy - citybiz.cocitybiz.co · Mon, 03 Aug 2026 14:35:45 GMTC&W: Advance eyes 524-unit fourth phase in Harrison with new equity partner, $173 million construction loan - Real Estate NJReal Estate NJ · Fri, 31 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 14:18:46 GMTVedanta Biosciences Raises $60 Million To Advance Phase 3 VE303 Study - Pulse 2.0
Thu, 06 Aug 2026 12:39:14 GMTPepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review - BioSpace
Thu, 06 Aug 2026 12:30:53 GMTVedanta Biosciences Raises $60 Million to Advance Phase 3 VE303 Program - citybiz.co
Thu, 06 Aug 2026 06:00:00 GMTPentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program - TradingView
Wed, 05 Aug 2026 12:02:58 GMTSanofi-backed Expedition uses $115M series B to advance COPD drug on phase 2 journey - Fierce Biotech
Tue, 04 Aug 2026 01:12:00 GMTNeurotech International (ASX:NTI) Raises $4.5 Million to Advance NTI164 Phase III Autism Clinical Trial - Kalkine

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Advance Phase.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.